<VariationArchive VariationID="655225" VariationName="NC_000005.10:g.(?_87268442)_(87353245_?)del" VariationType="Deletion" Accession="VCV000655225" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2019-08-14" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="651332" VariationID="655225">
      <GeneList>
        <Gene Symbol="CCNH" FullName="cyclin H" GeneID="902" HGNC_ID="HGNC:1594" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>5q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87311471" stop="87412930" display_start="87311471" display_stop="87412930" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86690078" stop="86708849" display_start="86690078" display_stop="86708849" Strand="-" />
          </Location>
          <OMIM>601953</OMIM>
        </Gene>
        <Gene Symbol="LOC644285" FullName="uncharacterized LOC644285" GeneID="644285" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>5q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87318415" stop="87323628" display_start="87318415" display_stop="87323628" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="RASA1" FullName="RAS p21 protein activator 1" GeneID="5921" HGNC_ID="HGNC:9871" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87267883" stop="87391916" display_start="87267883" display_stop="87391916" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86564069" stop="86687742" display_start="86564069" display_stop="86687742" Strand="+" />
          </Location>
          <OMIM>139150</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RASA1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RASA1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000005.10:g.(?_87268442)_(87353245_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" innerStart="87268442" innerStop="87353245" display_start="87268442" display_stop="87353245" variantLength="84804" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" innerStart="86564259" innerStop="86649062" display_start="86564259" display_stop="86649062" variantLength="84804" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.(?_87268442)_(87353245_?)del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.(?_87268442)_(87353245_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.(?_86564259)_(86649062_?)del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.(?_86564259)_(86649062_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000005.10:g.(?_87268442)_(87353245_?)del AND Capillary malformation-arteriovenous malformation 1" Accession="RCV000811353" Version="2">
        <ClassifiedConditionList TraitSetID="5197">
          <ClassifiedCondition DB="MedGen" ID="C4747394">Capillary malformation-arteriovenous malformation 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-12-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000005.10:g.(?_87268442)_(87353245_?)del AND Capillary malformation-arteriovenous malformation syndrome" Accession="RCV001385465" Version="6">
        <ClassifiedConditionList TraitSetID="52696">
          <ClassifiedCondition DB="MedGen" ID="C1842180">Capillary malformation-arteriovenous malformation syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-12-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-12-07" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5197" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="652" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Capillary malformation-arteriovenous malformation 1</ElementValue>
                <XRef ID="MONDO:0020783" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMAVM1</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CMAVM</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9787" />
                <XRef ID="9787" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</Attribute>
                <XRef ID="NBK52764" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21348050</ID>
                <ID Source="BookShelf">NBK52764</ID>
              </Citation>
              <XRef ID="137667" DB="Orphanet" />
              <XRef ID="90307" DB="Orphanet" />
              <XRef ID="C4747394" DB="MedGen" />
              <XRef ID="MONDO:0020783" DB="MONDO" />
              <XRef Type="MIM" ID="608354" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="52696" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="43207" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Capillary malformation-arteriovenous malformation</ElementValue>
                <XRef ID="Capillary+malformation-arteriovenous+malformation/7888" DB="Genetic Alliance" />
                <XRef ID="3994305" DB="NCBI for submitter" />
                <XRef Type="Phenotypic series" ID="PS608354" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Capillary malformation-arteriovenous malformation syndrome</ElementValue>
                <XRef ID="MONDO:0012016" DB="MONDO" />
                <XRef ID="468975" DB="NCBI for submitter" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11904" />
                <XRef ID="11904" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</Attribute>
                <XRef ID="NBK52764" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21348050</ID>
                <ID Source="BookShelf">NBK52764</ID>
              </Citation>
              <XRef ID="137667" DB="Orphanet" />
              <XRef ID="C1842180" DB="MedGen" />
              <XRef ID="MONDO:0012016" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS608354" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1845730" SubmissionDate="2019-03-28" DateLastUpdated="2019-08-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="5168287|MedGen:C1842180" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000951614" DateUpdated="2019-08-14" DateCreated="2019-08-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exons 1-9 of the RASA1 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 9Â¬â€ of the RASA1 gene. This is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RASA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_86564259)_(86649062_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Capillary malformation-arteriovenous malformation syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1842180" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3110967" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_002890.2_Deletion (Exons 1-9)|MedGen:C1842180" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585321" DateUpdated="2023-11-11" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exons 1-9 of the RASA1 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 9¬†of the RASA1 gene. This is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RASA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_86564259)_(86649062_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1842180" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1845730" TraitType="Disease" MappingType="Name" MappingValue="Capillary malformation-arteriovenous malformation syndrome" MappingRef="Preferred">
        <MedGen CUI="C1842180" Name="Capillary malformation-arteriovenous malformation syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3110967" TraitType="Disease" MappingType="XRef" MappingValue="C1842180" MappingRef="MedGen">
        <MedGen CUI="C1842180" Name="Capillary malformation-arteriovenous malformation syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

